Argenica Therapeutics (ASX:AGN) General and Admin. Expense: A$2.36 Mil (TTM As of Dec. 2025)


ASX:AGN Argenica Therapeutics Ltd ASX:AGN
33 GF Score
Price A$0.12
! 1 Warning Sign
View Full Analysis

What is Argenica Therapeutics General and Admin. Expense?

Argenica Therapeutics ASX:AGN +9.09% 33 General and Admin. Expense is A$2.36 Mil as of Dec. 2025. GuruFocus rates ASX:AGN with a GF Score™ of 33/100. The stock has 1 warning sign investors should review.

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. Argenica Therapeutics's General and Admin. Expense for the six months ended in Dec. 2025 was A$1.51 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Dec. 2025 was A$2.36 Mil.

Argenica Therapeutics General and Admin. Expense Related Terms

Argenica Therapeutics General and Admin. Expense Historical Data

* Premium members only.

The historical data trend for Argenica Therapeutics's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Argenica Therapeutics General and Admin. Expense Chart

Argenica Therapeutics Annual Data
Trend Jun21 Jun22 Jun23 Jun24 Jun25
General and Admin. Expense
0.79 1.75 2.11 2.07 2.23

Argenica Therapeutics Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
General and Admin. Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.99 1.08 1.38 0.86 1.51
ASX:AGN
33GF Score
Argenica Therapeutics Ltd ASX:AGN
General and Admin. Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Argenica Therapeutics General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

General and Admin. Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$2.36 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a General and Admin. Expense of A$2.36 Mil mean?
Argenica Therapeutics (ASX:AGN) has a General and Admin. Expense of A$2.36 Mil as of Dec. 2025. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on Argenica Therapeutics and its competitors.
Is Argenica Therapeutics' General and Admin. Expense too high?
Argenica Therapeutics' current General and Admin. Expense is A$2.36 Mil. Overall, Argenica Therapeutics has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Argenica Therapeutics' General and Admin. Expense compare to VRTX and REGN?
Argenica Therapeutics' General and Admin. Expense of A$2.36 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good General and Admin. Expense for a Biotechnology company?
A good General and Admin. Expense depends on the Biotechnology industry context. However, General and Admin. Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high General and Admin. Expense mean?
A high General and Admin. Expense can signal that a stock is expensive relative to its fundamentals. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on Argenica Therapeutics and its competitors. Argenica Therapeutics's current General and Admin. Expense is A$2.36 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Argenica Therapeutics stock overvalued right now?
Argenica Therapeutics (ASX:AGN) has a current General and Admin. Expense of A$2.36 Mil. The current General and Admin. Expense is A$2.36 Mil. Argenica Therapeutics' overall GF Score™ is 33/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is General and Admin. Expense calculated?
General and Admin. Expense is calculated from a company's financial statements. For Argenica Therapeutics (ASX:AGN), the current General and Admin. Expense is A$2.36 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Argenica Therapeutics Business Description

Address 117 Broadway, Unit 4, Nedlands, WA, AUS, 6009
Argenica Therapeutics Ltd is engaged in the research and development of novel drug candidates. Its ARG007 drug improves outcomes in pre-clinical stroke models and its non-clinical studies to other indications and regulatory consultants.
33GF Score

Get the complete analysis for ASX:AGN

General and Admin. Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.12
Price